Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Discover how bortezomib sensitizes glioblastoma with unmethylated MGMT promoter to temozolomide-chemotherapy through MGMT depletion and abrogated autophagy flux